Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Travel Vaccines Market
5.1 Market Performance
5.2 Market Breakup by Composition
5.3 Market Breakup by Disease
5.4 Market Breakup by Region
5.5 Market Forecast

6 North America Travel Vaccines Market
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast

7 North America Travel Vaccines Market: Breakup by Composition
7.1 Mono Vaccines
7.2 Combination Vaccines

8 North America Travel Vaccines Market: Breakup by Disease
8.1 Hepatitis A
8.2 DPT
8.3 Yellow Fever
8.4 Typhoid
8.5 Hepatitis B
8.6 Measles and Mumps
8.7 Rabies
8.8 Meningococcal
8.9 Varicella
8.10 Japanese Encephalitis
8.11 Others

9 North America Travel Vaccines Market: Breakup by Country
9.1 United States
9.1.1 Historical Market Trends
9.1.2 Market Breakup by Composition
9.1.3 Market Breakup by Disease
9.1.4 Market Forecast
9.2 Canada
9.2.1 Historical Market Trends
9.2.2 Market Breakup by Composition
9.2.3 Market Breakup by Disease
9.2.4 Market Forecast
9.3 Mexico
9.3.1 Historical Market Trends
9.3.2 Market Breakup by Composition
9.3.3 Market Breakup by Disease
9.3.4 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis
11.1 Overview
11.2 Exploratory Stage
11.3 Preclinical and Clinical Development
11.4 Regulatory Approval
11.5 Manufacturing
11.6 Marketing and Distribution

12 Porter’s Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Rivalry
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players

List of Figures

Figure 1: North America: Travel Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Travel Vaccines Market: Value Trends (in Billion US$), 2016-2021
Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2021
Figure 6: Global: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2022-2027
Figure 7: North America: Travel Vaccines Market: Value Trends (in Billion US$), 2016-2021
Figure 8: North America: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2022-2027
Figure 9: North America: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 10: North America: Travel Vaccines (Mono Vaccines) Market: Value Trends (in Million US$), 2016 & 2021
Figure 11: North America: Travel Vaccines (Mono Vaccines) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 12: North America: Travel Vaccines (Combination Vaccines) Market: Value Trends (in Million US$), 2016 & 2021
Figure 13: North America: Travel Vaccines (Combination Vaccines) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 14: North America: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 15: North America: Travel Vaccines (Hepatitis A) Market: Value Trends (in Million US$), 2016 & 2021
Figure 16: North America: Travel Vaccines (Hepatitis A) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 17: North America: Travel Vaccines (DPT) Market: Value Trends (in Million US$), 2016 & 2021
Figure 18: North America: Travel Vaccines (DPT) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 19: North America: Travel Vaccines (Yellow Fever) Market: Value Trends (in Million US$), 2016 & 2021
Figure 20: North America: Travel Vaccines (Yellow Fever) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 21: North America: Travel Vaccines (Typhoid) Market: Value Trends (in Million US$), 2016 & 2021
Figure 22: North America: Travel Vaccines (Typhoid) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 23: North America: Travel Vaccines (Hepatitis B) Market: Value Trends (in Million US$), 2016 & 2021
Figure 24: North America: Travel Vaccines (Hepatitis B) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 25: North America: Travel Vaccines (Measles and Mumps) Market: Value Trends (in Million US$), 2016 & 2021
Figure 26: North America: Travel Vaccines (Measles and Mumps) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 27: North America: Travel Vaccines (Rabies) Market: Value Trends (in Million US$), 2016 & 2021
Figure 28: North America: Travel Vaccines (Rabies) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 29: North America: Travel Vaccines (Meningococcal) Market: Value Trends (in Million US$), 2016 & 2021
Figure 30: North America: Travel Vaccines (Meningococcal) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 31: North America: Travel Vaccines (Varicella) Market: Value Trends (in Million US$), 2016 & 2021
Figure 32: North America: Travel Vaccines (Varicella) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 33: North America: Travel Vaccines (Japanese Encephalitis) Market: Value Trends (in Million US$), 2016 & 2021
Figure 34: North America: Travel Vaccines (Japanese Encephalitis) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 35: North America: Travel Vaccines (Others) Market: Value Trends (in Million US$), 2016 & 2021
Figure 36: North America: Travel Vaccines (Others) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 37: North America: Travel Vaccines Market: Breakup by Country (in %), 2021
Figure 38: United States: Travel Vaccines Market: Value Trends (in Million US$), 2016-2021
Figure 39: United States: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 40: United States: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 41: United States: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 42: Canada: Travel Vaccines Market: Value Trends (in Million US$), 2016-2021
Figure 43: Canada: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 44: Canada: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 45: Canada: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 46: Mexico: Travel Vaccines Market: Value Trends (in Million US$), 2016-2021
Figure 47: Mexico: Travel Vaccines Market: Breakup by Composition (in %), 2021
Figure 48: Mexico: Travel Vaccines Market: Breakup by Disease (in %), 2021
Figure 49: Mexico: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 50: North America: Travel Vaccines Industry: SWOT Analysis
Figure 51: North America: Travel Vaccines Industry: Value Chain Analysis
Figure 52: North America: Travel Vaccines Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: North America: Travel Vaccines Market: Key Industry Highlights, 2021 and 2027
Table 2: North America: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2022-2027
Table 3: North America: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2022-2027
Table 4: North America: Travel Vaccines Market Forecast: Breakup by Country (in Million US$), 2022-2027
Table 5: North America: Travel Vaccines Market: Competitive Structure
Table 6: North America: Travel Vaccines Market: Key Players